Business Development

Licensing Opportunities

Axela is focused on biomedical research transitioning to clinical diagnostics as its primary market(s). The versatility of the technology to address other markets is apparent. The flow-through configuration of the sensor and broad range of analyte types means that dot® technology can be leveraged broadly across many different markets.

As part of its strategy to exploit market potential, Axela has expanded its business model to include agricultural biotechnology. Opportunities exist in the areas of:

• Animal Health
• Environmental Testing
• Food Safety
• Plant Agriculture

Mr. Butch Mercer, CEO BioMark™ is currently identifying partners for Axela’s technology in these areas. For discussions regarding the application of dotLab® technology in agricultural biotechnology please contact Mr. Mercer at the address below. Inquiries regarding other applications of Axela’s dotLab technology can be made to, Mr. Owen Gordon at the address below.

See Press Release: Axela Expands Market Presence in Agricultural Biotechnology Sector and Hires Industry Veteran, Butch Mercer, CEO BioMark™ to Identify Potential Partners

See Interview: Nonclinical IVDs: Growing interest in a growing field

Contact Information

Clinical researchers and commercial partners are encouraged to contact us for further discussion. Please inquire with either: